Matthew Schipper

If you are interested in external control arms in clinical trials and related topics, come join us Mon afternoon!

Special talk this afternoon- The inaugural Felix Feng Visiting Professorship. Dr. Paul Nguyen did phenomenal job highlighting the impact Felix had on so many of us.

NEW: A novel tool predicts long-term risk of dying from #ProstateCancer, helping doctors interpret PSA results more accurately. Tested on over 200K men, it could help doctors tailor screening and treatment to individual risk and life expectancy. Read now: bit.ly/4pHyUwz @stensy @wandering_gu @UMichUrology #Cancer #CancerScreening

@umichepid @umichsph Still time to register.

Enhance your expertise in public health with our Summer Session in Epidemiology. Online from July 7-25, you'll gain skills in design and analysis of clinical trials from Dr. Matthew Schipper @StatMatt9 @umichsph

@UPennDBEI Congratulations Qi!

Dr. Qi Long has been named a Fellow of the Institute of Mathematical Statistics (IMS) for his significant contributions to statistics, data science, and his leadership in applying these to biomedicine. Congratulations to Dr. Long! Read more: bit.ly/43Q2aIp

Interesting timely article from @statnews statnews.com/2025/06/06/us-…

@emilyk_roberts @UIowaCPH @Iowa_Biostat Congratulations Emily!

Honored to receive a @UIowaCPH Faculty Teaching Award! Hard to believe I'm wrapping up my third academic year at @Iowa_Biostat

Congratulations to Matt Schipper (@StatMatt9) for winning the @UMich Research Faculty Mentor Award. Matt has a tremendous record of supporting and training dozens of students, staff, trainees, and faculty, so this is very well-deserved! @UMichRadOnc @UMRogelCancer @MichRadOncRes

@Dan_ChangMD @UMich @UMichRadOnc @UMRogelCancer @MichRadOncRes Thanks Dan! I've benefited a lot from great mentorship so it is a privilege to pass that on to others.

jamanetwork.com/journals/jamao… Nice editorial about 'skimming' the median - 1 number will not fully capture difference between 2 curves.

@DrSpratticus @SeanMcGuireMD @JoeBiden Yes plenty of events to train model with 8 predictors. More important was external validation on over 8000 men with over 2000 events.

@SeanMcGuireMD @JoeBiden Over 450 events. Plenty for training and then validated in PLCO. @StatMatt9

Ppl understandably bring up concerns on a population level with expanding screening in men >70yo. Let us dive into data on this. I agree with @VickersBiostats we should always do 'risk stratified' screening whether >70 or <70yo (we should not be doing PSA screening in a 50 yo with a terminal condition with <1yr to live). @ASTRO_org @ASCO @PCF_Science

A study from the @VAAnnArbor provides more data on the impact of lung cancer screening, this time evaluating the survival of a cohort of >2,000 screen-detected lung cancers. acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

@cwspeers @UMichRadOnc @RadOncUH @DrSpratticus @UABmedphys @UABradonc Congratulations Corey!

Couldn’t be more grateful for amazing colleagues and mentors @UMichRadOnc and @RadOncUH and especially @DrSpratticus. Incredibly humbled and honored to join amazing groups @UABmedphys @UABradonc . Excited for what the future holds for the department, school, community, and field!

It is with profound sadness that we mourn the passing of Felix Feng—an incredible father, husband, UCSF leader, pioneering scientist, entrepreneur, mentor, and cherished friend. Felix’s enduring kindness, brilliant mind, generous spirit, and transformative work in prostate cancer research have touched and saved countless lives. His legacy of compassion, innovation, and excellence will continue to inspire us all. My deepest condolences to Mary, Eric, & Emily during this heartbreaking time. May the One who brings Peace bring Peace to All.💔

Effectiveness and safety of immune checkpoint inhibitors in Black patients versus White patients in a US national health system: a retrospective cohort study Out on Lancet Oncology This retrospective cohort study aimed to evaluate the effectiveness and safety of immune checkpoint inhibitors (ICIs) in Black patients, who were underrepresented in clinical trials leading to ICIs’ approval. Using data from the U.S. Veterans Health Administration, the study included 26,398 patients, of whom 18.7% were Black and 81.3% were White. Results showed that Black patients had a longer time to treatment discontinuation, similar time to next treatment, and slightly improved overall survival compared to White patients. Additionally, Black patients experienced significantly fewer immune-related adverse events, including lower risks of colitis and thyroid issues. These findings suggest that Black patients may have a more favorable therapeutic ratio for ICI treatment, though further investigation is needed to assess the generalizability of these results. @StatMatt9 @garthstrohbehn @DariaBrinzevich @KamyaSankar buff.ly/4fBgtpa

@Soum_Roy_RadOnc @NicholasZaorsky @UHhospitals @RadOncUH @CWRUSOM @cwru @CaseUrology I was just trying to explain to my six-year-old daughter that I am like a fake doctor. Reminded me of @stephensenn def of statistician as one who has neither the intellect for mathematics nor the commitment for medicine, but likes to dabble in both.

@StatMatt9 @NicholasZaorsky @UHhospitals @RadOncUH @CWRUSOM @cwru @CaseUrology Dr. Schipper, I consider myself a fake statistician 😅😅.

Recently learned that @Soum_Roy_RadOnc is presenting research at same session at #ASTRO24, he was a top gold medal mathematician/biostatistician in India, and he will be joining the genitourinary cancer team at @UHhospitals @RadOncUH @CWRUSOM @cwru @CaseUrology

@Soum_Roy_RadOnc @NicholasZaorsky @UHhospitals @RadOncUH @CWRUSOM @cwru @CaseUrology More like a statistician who know his area of collaboration quite well 🤣

@felixfengmd @MaryFengMD @ASTRO_org Congratulations Felix and Mary! It was great to see you both again!